16304-39-5 Usage
Description
5-Hydroxybenzo[b]thiophene-3-carboxylic acid is an organic compound characterized by the presence of a hydroxyl group attached to a benzothiophene ring and a carboxylic acid group. It is known for its unique chemical structure and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
5-Hydroxybenzo[b]thiophene-3-carboxylic acid is used as a reactant in the synthesis of derivatives of prostaglandin D2 receptor antagonists with a 6,6-dimethylbicyclo[3.1.1]heptane skeleton. These derivatives have potential applications in the development of antiallergic drugs, as they can help modulate the immune response and alleviate allergic symptoms.
Additionally, due to its chemical structure, 5-hydroxybenzo[b]thiophene-3-carboxylic acid may also be utilized in the synthesis of other bioactive compounds, contributing to the advancement of pharmaceutical research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 16304-39-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,3,0 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16304-39:
(7*1)+(6*6)+(5*3)+(4*0)+(3*4)+(2*3)+(1*9)=85
85 % 10 = 5
So 16304-39-5 is a valid CAS Registry Number.
16304-39-5Relevant articles and documents
Process for the preparation of pgd2 antagonist
-
Page/Page column 5, (2010/01/31)
The present invention provides an efficient process for the preparation of benzothiophenecarboxamide PGD2 antagonist, S-5751.
Process for preparing 5-hydroxybenzo [b] thiophene-3-carboxylic acid derivatives
-
Page column 18, (2010/02/04)
Processes for producing compounds of the formula (VI) are disclosed. Benzothiophenecarboxylic acid derivatives of the formula (I), which are useful as starting materials for producing drugs, are disclosed. Particularly, disclosed is a process for preparin
Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them
-
, (2008/06/13)
PCT No. PCT/JP97/04527 Sec. 371 Date May 17, 1999 Sec. 102(e) Date May 17, 1999 PCT Filed Dec. 10, 1997 PCT Pub. No. WO98/25919 PCT Pub. Date Jun. 18, 1998A compound, a pharmaceutically acceptable salt thereof, or a hydrate thereof having PGD2-antagonisti